Northern Trust’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$220K Hold
66,682
﹤0.01% 3908
2025
Q1
$191K Hold
66,682
﹤0.01% 3959
2024
Q4
$155K Sell
66,682
-4,358
-6% -$10.1K ﹤0.01% 4061
2024
Q3
$224K Hold
71,040
﹤0.01% 3847
2024
Q2
$157K Buy
71,040
+8,378
+13% +$18.5K ﹤0.01% 3935
2024
Q1
$196K Buy
62,662
+11,165
+22% +$34.8K ﹤0.01% 3903
2023
Q4
$200K Sell
51,497
-1,947
-4% -$7.55K ﹤0.01% 3900
2023
Q3
$175K Sell
53,444
-418
-0.8% -$1.37K ﹤0.01% 3867
2023
Q2
$172K Sell
53,862
-4,611
-8% -$14.8K ﹤0.01% 3880
2023
Q1
$251K Sell
58,473
-42
-0.1% -$181 ﹤0.01% 3750
2022
Q4
$249K Hold
58,515
﹤0.01% 3763
2022
Q3
$288K Buy
58,515
+1,597
+3% +$7.86K ﹤0.01% 3696
2022
Q2
$174K Hold
56,918
﹤0.01% 3982
2022
Q1
$156K Sell
56,918
-3,311
-5% -$9.08K ﹤0.01% 4212
2021
Q4
$179K Sell
60,229
-1,053
-2% -$3.13K ﹤0.01% 4234
2021
Q3
$292K Hold
61,282
﹤0.01% 3996
2021
Q2
$238K Buy
61,282
+12,195
+25% +$47.4K ﹤0.01% 4080
2021
Q1
$230K Sell
49,087
-204
-0.4% -$956 ﹤0.01% 4063
2020
Q4
$151K Sell
49,291
-2,721
-5% -$8.34K ﹤0.01% 4031
2020
Q3
$127K Buy
52,012
+6,291
+14% +$15.4K ﹤0.01% 3908
2020
Q2
$140K Sell
45,721
-8,001
-15% -$24.5K ﹤0.01% 3845
2020
Q1
$86K Buy
53,722
+100
+0.2% +$160 ﹤0.01% 3854
2019
Q4
$176K Sell
53,622
-2,371
-4% -$7.78K ﹤0.01% 3816
2019
Q3
$224K Sell
55,993
-3,000
-5% -$12K ﹤0.01% 3734
2019
Q2
$214K Hold
58,993
﹤0.01% 3809
2019
Q1
$267K Buy
58,993
+338
+0.6% +$1.53K ﹤0.01% 3707
2018
Q4
$231K Buy
58,655
+17,147
+41% +$67.5K ﹤0.01% 3765
2018
Q3
$193K Buy
41,508
+4,960
+14% +$23.1K ﹤0.01% 3876
2018
Q2
$111K Hold
36,548
﹤0.01% 3994
2018
Q1
$140K Buy
36,548
+16,248
+80% +$62.2K ﹤0.01% 3893
2017
Q4
$48K Buy
20,300
+4,599
+29% +$10.9K ﹤0.01% 4077
2017
Q3
$41K Buy
+15,701
New +$41K ﹤0.01% 4083